Nykode Therapeutics Initiates Phase 2 Trial of VB10.16 in Second Line HPV16-Positive Cervical Cancer
April 19, 2024 01:00 ET
|
Nykode Therapeutics ASA
OSLO, Norway, April 19, 2024 (GLOBE NEWSWIRE) -- Nykode Therapeutics ASA (OSE: NYKD), a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel immunotherapies,...
Annual report 2023 + general shareholders meeting
April 19, 2024 01:00 ET
|
Unifiedpost
We are delighted and proud to present the annual report of Unifiedpost for the year 2023. You can find the report on the investor relations website of the Company, together with the information about...
CONVENING NOTICE TO THE ORDINARY GENERAL MEETINGS OF SHAREHOLDERS
April 19, 2024 01:00 ET
|
Unifiedpost
UNIFIEDPOST GROUP Public limited liability company (“naamloze vennootschap”. / “société anonyme“) under Belgian law Registered office at Avenue Reine Astrid 92A, 1310 La Hulpe, BelgiumCompany...
Addex to Present at the Swiss Biotech Day 2024
April 19, 2024 01:00 ET
|
Addex Therapeutics
Geneva, Switzerland, April 19, 2024 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug development, announced today that...
Construction contract in Latvia (solar panel power plant in Vārme parish)
April 19, 2024 01:00 ET
|
Merko Ehitus AS
On 18 April 2024, PS MB.MEE, part of AS Merko Ehitus group, and SIA SP Venta, which sole shareholder and financier of the project development is UAB Ignitis renewables, entered into a contract to for...
Global Low-Speed Vehicle Market Size To Exceed USD 28.57 Billion By 2033 | CAGR of 9.32%
April 19, 2024 01:00 ET
|
SPHERICAL INSIGHTS LLP
New York, United States, April 19, 2024 (GLOBE NEWSWIRE) -- The Global Low-Speed Vehicle Market Size is to Grow from USD 11.72 Billion in 2023 to USD 28.57 Billion by 2033, at a Compound Annual...
Pluxee delivers strong performance in the First Half and raises Fiscal 2024 Organic revenue growth and Recurring EBITDA margin objectives
April 19, 2024 01:00 ET
|
Pluxee International
First Half Fiscal 2024 ResultsIssy-les-Moulineaux, France – April 19, 2024 First Half Fiscal 2024 highlights Successful spin-off and listing on Euronext Paris on February 1, 2024 Organic revenue...
Sodexo announces solid H1 Fiscal 2024 results
April 19, 2024 01:00 ET
|
Sodexo SA
Issy-les-Moulineaux, April 19, 2024 Sodexo (Euronext Paris FR 0000121220-OTC: SDXAY) Sodexo announces solid H1 Fiscal 2024 results Organic Revenue growth +8.5%Underlying operating profit +16.9%...
FDA approves Roche’s Alecensa as the first adjuvant treatment for people with ALK-positive early-stage lung cancer
April 19, 2024 01:00 ET
|
F. Hoffmann-La Roche Ltd
Approval based on Phase III ALINA study showing Alecensa reduced the risk of disease recurrence or death by an unprecedented 76% in people with ALK-positive early-stage resected non-small cell lung...
Start of Day Message
April 19, 2024 01:00 ET
|
GlobeNewswire, Inc.
LONDON, 19 Apr. 2024 (GLOBE NEWSWIRE) -- This is the Start of Day Message for GlobeNewswire. GlobeNewswire is operated by Notified and is designated by the FCA as an approved primary information...